Recruiting Rheumatoid Arthritis Studies in Farmington
Evaluation of Oral Tofacitinib in Children Aged 2 to 17 Years Old Suffering From Moderate to Severe Ulcerative Colitis
This study, A3921210 is designed to evaluate the efficacy, safety and pharmacokinetics (PK) of tofacitinib in pediatric participants with moderately to severely active UC. In the US and EU, patients w...
A Study of mRNA-3745 in Adult and Pediatric Participants With Glycogen Storage Disease Type 1a (GSD1a)
The main goal of this trial is to evaluate the safety and tolerability of mRNA-3745 via intravenous (IV) administration in adult and pediatric participants with GSD1a....
A Phase 1/2, Dose-Exploration Study to Evaluate the Safety and Efficacy of BEAM-301 in Patients With Glycogen Storage Disease Type Ia (GSDIa)
This is a Phase 1/2, multicenter, open-label, single-ascending-dose study to evaluate the safety, tolerability, and efficacy of BEAM-301 in adult patients with GSDIa homozygous or compound heterozygou...
About Rheumatoid Arthritis Clinical Trials in Farmington
Rheumatoid arthritis (RA) is a chronic autoimmune disease affecting approximately 1.3 million Americans, where the immune system mistakenly attacks joint linings, causing painful swelling, bone erosion, and joint deformity. Early diagnosis and treatment are critical to prevent irreversible damage. Current standard treatments include methotrexate and other DMARDs, TNF inhibitors (etanercept, infliximab), IL-6 inhibitors (tocilizumab), T-cell costimulation modulators (abatacept), and JAK inhibitors (tofacitinib, baricitinib). Clinical trials are now exploring next-generation targeted therapies, dual-pathway inhibitors, and treatment strategies aimed at achieving sustained remission rather than just symptom control. Patients with inadequate response to conventional DMARDs or biologics are commonly eligible for enrollment.
There are currently 3 rheumatoid arthritis clinical trials recruiting participants in Farmington, CONNECTICUT. These studies are seeking a combined 201 participants. Research is being sponsored by Pfizer, ModernaTX, Inc., Beam Therapeutics Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Rheumatoid Arthritis Clinical Trials in Farmington — FAQ
Are there rheumatoid arthritis clinical trials in Farmington?
Yes, there are 3 rheumatoid arthritis clinical trials currently recruiting in Farmington, CONNECTICUT. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Farmington?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Farmington research site will contact you about next steps.
Are clinical trials in Farmington free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Farmington studies also compensate for your time and travel.
What rheumatoid arthritis treatments are being tested?
The 3 active trials in Farmington are testing new therapies including novel drugs, biologics, and treatment approaches for rheumatoid arthritis.
Data updated March 2, 2026 from ClinicalTrials.gov